vopemed Secures $2.29M CAD Pre-Seed Funding to Redefine Surgical Visualization with AI
Vope Medical, a MedTech startup based in Montreal, has successfully raised $2.29 million in pre-seed funding. The funding will be used to further develop and validate their AI-powered image clarification technology for surgical use. The round was oversubscribed, indicating strong investor interest in the company's innovative approach to enhancing surgical vision. Vope Medical aims to revolutionize the field of surgery by leveraging AI technology to improve visual clarity during procedures. The company's success in securing this funding highlights the growing importance of MedTech advancements in the healthcare industry.
MONTRÉAL, April 2, 2025 - Vopemed (Vope Medical), a pioneering MedTech startup enhancing surgical vision with AI-powered image clarification, has secured an oversubscribed $2.29 million pre-seed funding round to accelerate the development and clinical validation of its technology. This funding marks a significant milestone in Vopemed's vision of empowering surgical teams with next-generation tools for safer, more efficient surgeries.
AI-Powered Image Enhancement for Surgical Vision
Vopemed is developing Claris, an AI-driven image enhancement software designed to improve the clarity of laparoscopic and robotic-assisted procedure video feeds in real-time, leading to safer surgeries. "This funding validates the need for enhanced surgical visualization and reinforces our mission to bring AI-powered image enhancement into every operating room," said Amy Lorincz, CEO and co-founder of Vopemed. "Current solutions fail to address persistent visibility challenges in minimally invasive surgery, and Claris is designed to solve this unmet need."
Support and Potential Impact
"We are excited to support Vopemed as they bring AI-driven image enhancement to surgery," said Jacques Courtois of Genson Capital Inc. "Their technology has the potential to significantly improve surgical precision and efficiency, and we believe they are well-positioned to make a lasting impact in MedTech." "Clear visualization is critical for precise surgical decisions, especially in minimally invasive procedures. AI-driven image enhancement like Claris could be a game-changer in improving efficiency and patient outcomes," said Dr. Dicken Ko, Urologic Surgeon, Professor of Surgery at The Warren Alpert Medical School of Brown University.
Investment and Future Plans
The pre-seed round was led by Genson Capital Inc., which invested $1.5 million CAD, and Investissement Québec, as a mandated agent of the gouvernement du Québec, which contributed $750,000 CAD. These investors bring valuable support to life science and medical device companies, enabling them to advance innovation and scale in a regulated industry. With the funds secured, Vopemed will expand R&D, refine its software for broader clinical applications, and strengthen partnerships with hospitals and surgical teams. The company is also preparing for clinical validation studies to further demonstrate Claris' impact in real-world settings.
About Vopemed
Vopemed is a MedTech startup dedicated to enhancing surgical vision with AI-powered image clarification technology. Its flagship product, Claris, integrates seamlessly with existing surgical systems to provide real-time, high-clarity imaging, reducing visual obstructions and improving visualization in minimally invasive surgery. The company is committed to redefining surgery by equipping surgical teams with cutting-edge tools for safer, more efficient procedures.
SOURCE: Vopemed